PharmaBoardroom

Interview: Giorgio Calderari – Chairman, Farma Industria…

With a population of only 350,000, Ticino has a remarkably well developed pharmaceutical cluster. FIT Chairman Giorgio Calderari explains that the…

Interview: Terry Lin – General Manager & Freia Wei…

Terry Lin, general manager, and Freia Wei, director for international business at UniPharma, on the company’s move from specialty distribution to…

Interview: Maarten Pouw – BU Director Mexico & Latin…

Maarten Pouw, business unit director of Mexico and Latin America at DSM Sinochem Pharmaceuticals, explains the crucial role that sustainable…

Trump and Pharma: A Mixed Bag

While pledging to lower drug prices has proved popular, the Trump administration’s proposed FDA reform has been getting some pharmaceutical…

Interview: Yita Lee Ph.D – Deputy Chairman, Sinphar Group;…

Yita Lee & Muh-Hwan Su of Sinphar Group & SynCore Bio describe the exciting R&D projects of SynCore Bio, the oncology & dry AMD…

Interview: Tom Coogan – General Manager, Grünenthal…

Grünenthal Ireland’s General Manager discusses the incredible growth of the Irish affiliate over the past twelve years, their comprehensive pain…

Interview: Piero Poli – President & CEO, Rivopharm,…

Niche generics manufacturer Rivopharm was nearly bankrupt when acquired by current president and CEO Piero Poli in 2005; he explains the changes and…

Putting the ‘R’ & ‘D’ back into…

“Ireland is on a fantastic trajectory in terms of our innovative output and the quality of Irish science." Professor Mark Ferguson, Science…

Mihalis Himonas – General Manager, SFEE (Hellenic…

General Manager of the Hellenic Association of Pharmaceutical Companies (SFEE), Mihalis Himonas speaks about his role spearheading Greece’s main…

Interview: Jonas Wang, Ph.D. – Chairman & CEO,…

Jonas Wang Ph.D., Chairman and CEO of StemCyte, a global leader in Regenerative Therapy field including cell processing and transplantation located in…

Interview: Sorcha McKenna – Partner, McKinsey &…

Sorcha McKenna, Partner at McKinsey & Company in Ireland, discusses the current trends in the Irish healthcare and life sciences sector, the…

Optimism for the Pharma Industry in 2017

Do phenomenons such as Brexit and the Trump election victory mean trouble for the pharma industry or are you more optimistic? Take the PharmaBoardroom…

Tagged with A